FrancophonIA/ELRC3.0 huggingface dataset:
English: • liver disorders, such as jaundice, enlarged liver or fatty liver, inflammation (hepatitis)
Danish: • leversygdomme som gulsot, forstørret lever eller fedtlever, leverbetændelse (hepatitis)
English: Pancreatitis has been reported, but a causal relationship to lamivudine and abacavir is uncertain.
Danish: Pancreatitis er rapporteret, men kausal sammenhæng med lamivudin og abacavir er usikker.
English: • Emtricitabine, to treat HIV infection
Danish: • emtricitabin, til behandling af hiv-infektion.
English: It is not known whether abacavir can be removed by peritoneal dialysis or haemodialysis.
Danish: Det vides ikke, om abacavir kan fjernes ved peritonealdialyse eller hæmodialyse.
English: What you need to know before you take Kivexa
Danish: Det skal du vide, før du begynder at tage Kivexa
English: In pregnant women treated with lamivudine, more than 1000 outcomes from first trimester and more than 1000 outcomes from second and third trimester exposure indicate no malformative and foeto/neonatal effect.
Danish: Hos gravide kvinder behandlet med lamivudin har flere end 1.000 eksponeringer i første trimester og flere end 1.000 eksponeringer i andet og tredje trimester ikke indikeret misdannende eller føtale/neonatale effekter.
English: Neither abacavir nor lamivudine were mutagenic in bacterial tests, but consistent with other nucleoside analogues, they inhibit cellular DNA replication in in vitro mammalian tests such as the mouse lymphoma assay.
Danish: Hverken abacavir eller lamivudin var mutagene i bakterieforsøg, men i analogi med andre nukleosidanaloger hæmmer de cellulær DNA-replikation i in vitro test med celler fra pattedyr, såsom i lymfetesten udført på mus.
English: Pains in the joints or muscles, swelling of the neck, shortness of breath, sore throat, cough, occasional headaches, inflammation of the eye (conjunctivitis), mouth ulcers, low blood pressure, tingling or numbness of the hands or feet.
Danish: Smerter i led og/eller muskler, hævelse af halsen, åndenød, ondt i halsen, hoste, lejlighedsvis hovedpine, øjenbetændelse (konjunktivit), mundsår, lavt blodtryk, snurren eller følelsesløshed i hænder og/eller fødder.
English: Cimetidine eliminated only in part by renal organic cation transport system.
Danish: cimetidin elimineres kun delvist via det renale organisk kation transportsystem.
English: When possible, avoid chronic coadministration of Kivexa with medicinal products containing sorbitol or other osmotic acting poly-alcohols or monosaccharide alcohols (e.g. xylitol, mannitol, lactitol, maltitol).
Danish: Undgå så vidt muligt vedvarende administration af Kivexa sammen med sorbitolholdige lægemidler eller andre osmotisk virkende polyalkoholer eller monosaccaharidalkoholer (f.eks. xylitol, mannitol, lactitol, maltitol).
English: The mean time to maximal serum concentrations (tmax) is about 1.5 hours and 1.0 hour for abacavir and lamivudine, respectively.
Danish: Efter oral administration er gennemsnitstiden (tmax) for at opnå maksimal serumkoncentration (Cmax) omkring 1,5 time og 1,0 time for henholdsvis abacavir og lamivudin.
English: It is important to read the information later in this section under ‘Other possible side effects of combination therapy for HIV'.
Danish: Det er vigtigt, at du læser oplysningerne under 'Andre bivirkninger ved kombinationsbehandling af hiv' senere i dette afsnit.
English: Trimethoprim/sulfamethoxazole (Co-trimoxazole)/Lamivudine (160 mg/800 mg once daily for 5 days/300 mg single dose)
Danish: Trimethoprim/sulfamethoxazol (sulfa/trim) / lamivudin (160 mg / 800 mg én gang daglig i 5 dage / 300 mg enkeltdosis)
English: The EU RMP of the abacavir (ABC) containing products (Ziagen, Kivexa and Trizivir) includes the following risk minimisation plan in relation to abacavir hypersensitivitiy reaction (HSR), which is an important identified risk:
Danish: • Yderligere risikominimeringsforanstaltninger EU-RMP'en for præparaterne (Ziagen, Kivexa og Trizivir), der indeholder abacavir (ABC), inkluderer følgende risikominimeringsplan for overfølsomhedsreaktion over for abacavir (ABCoverfølsomhedsreaktion), som er en vigtig identificeret risiko:
English: At week 48, a lower rate of virologic response was observed for ABC/3TC compared to TDF/FTC (point estimate for the treatment difference: 11.6%, 95% CI: 2.2, 21.1).
Danish: Ved uge 48 blev et lavere virologisk respons observeret for ABC/3TC sammenlignet med TDF/FTC (punktestimat for behandlingsforskel: 11,6 %; 95 % CI: 2,2; 21,1).
English: Interaction not studied
Danish: Ingen interaktionsstudier
English: If you have discontinued Kivexa due to this reaction, YOU MUST NEVER TAKE Kivexa, or any medicine containing abacavir (e.g. Ziagen,Triumeq or Trizivir) again as within hours you may experience a life-threatening lowering of your blood pressure or death.
Danish: Hvis du er stoppet med at tage Kivexa på grund af denne reaktion, MÅ DU ALDRIG TAGE Kivexa eller andre lægemidler indeholdende abacavir (f.eks. Ziagen, Triumeq eller Trizivir) igen, da du inden for timer kan risikere et livstruende fald i blodtrykket eller at dø.
English: Patients were stratified at screening based on plasma HIV-1 RNA levels < 100,000 and ≥ 100,000 copies/mL.
Danish: Patienterne blev stratificeret ved en screening baseret på plasmaniveau af hiv-1-RNA på < 100.000 kopier /ml og ≥ 100.000 kopier/ml.
English: In any case, initiation of susceptible NRTIs should always be preferred to maintenance of lamivudine therapy.
Danish: Behandling med andre NRTI'er vil under alle omstændigheder være at foretrække frem for at fortsætte behandling med lamivudin.
English: Based on data obtained for abacavir, Kivexa is not recommended in patients with moderate or severe hepatic impairment.
Danish: Baseret på data for abacavir, anbefales Kivexa ikke til patienter med moderat til svært nedsat leverfunktion.
English: Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk of severe and potentially fatal hepatic adverse reactions.
Danish: Patienter med kronisk hepatitis B eller C, behandlet med antiretroviral kombinationsbehandling, har større risiko for alvorlige og potentielt letale leverbivirkninger.
English: Common: hypersensitivity
Danish: Almindelig: Overfølsomhed
English: The adverse reactions reported for Kivexa were consistent with the known safety profiles of abacavir and lamivudine when given as separate medicinal products.
Danish: Bivirkninger rapporteret for Kivexa svarer til de sikkerhedsprofiler som er kendt for abacavir og lamivudin, når disse gives som separate lægemidler.
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported to occur in the setting of immune reactivation; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment.
Danish: Autoimmune sygdomme (som f.eks. Graves´ sygdom og autoimmun hepatitis) er også blevet rapporteret i forbindelse med immunreaktivering; dog er den rapporterede tid til frembrud mere variabel, og frembrud kan forekomme mange måneder efter behandlingsstart.
English: Abacavir and lamivudine are rapidly and well absorbed from the gastro-intestinal tract following oral administration.
Danish: Abacavir og lamivudin absorberes hurtigt og godt fra mave-tarmkanalen efter oral administration.
English: Phenotypic resistance and cross-resistance
Danish: Fænotyperesistens og krydsresistens
English: Common: Headache, insomnia.
Danish: Almindelig: Hovedpine, søvnløshed
English: Baseline HIV-1 samples from therapy-naive subjects with no amino acid substitutions associated with resistance have been evaluated using either the multi-cycle Virco Antivirogram™ assay (n=92 from COL40263) or the the single cycle Monogram Biosciences PhenoSense™ assay (n=138 from ESS30009).
Danish: Baseline-hiv-1-prøver fra behandlingsnaive forsøgspersoner uden aminosyre-substitutioner relateret til resistens er evalueret ved brug af enten ”multi-cycle” Virco Antivirogram™ assay (n=92 fra COL40263) eller ”single-cycle” Monogram Biosciences PhenoSense™ assay (n=138 fra ESS30009).
English: Hypersensitivity reactions can start at any time during treatment with Kivexa, but are more likely during the first 6 weeks of treatment.
Danish: En overfølsomhedsreaktion kan opstå på et hvilket som helst tidspunkt under behandling med Kivexa, men optræder normalt i de første 6 uger af behandlingen.
English: Following a single dose of 600 mg of abacavir, the mean (CV) Cmax is 4.26 µg/ml (28%) and the mean (CV) AUC∞ is 11.95 µg.h/ml (21%).
Danish: Efterfølgende en enkeltdosis af 600 mg abacavir er (CV) Cmax 4,26 µg/ml (28 %) og (CV) AUC∞ er 11,95 µg · t/ml (21 %).
English: • inflammation of the pancreas (pancreatitis)
Danish: • betændelse i bugspytkirtlen (pankreatitis)
English: The adverse reactions considered at least possibly related to abacavir or lamivudine are listed by body system, organ class and absolute frequency.
Danish: De bivirkninger, der anses for at kunne relateres til behandlingen, er nævnt nedenfor fordelt efter organklasser og absolut frekvens.
English: If you have stopped taking Kivexa
Danish: Hvis du holder op med at tage Kivexa
English: MISCELLANEOUS Ethanol/Abacavir (0.7 g/kg single dose/600 mg single dose)
Danish: Ethanol / abacavir (0,7 g/kg enkeltdosis / 600 mg enkeltdosis)
English: Other key symptoms include gastrointestinal, respiratory or constitutional symptoms such as lethargy and malaise.
Danish: Andre vigtige symptomer omfatter gastrointestinale, respiratoriske eller almene symptomer som svær udmatning og utilpashed
English: In a study of 20 HIV-infected patients receiving abacavir 300 mg twice daily, with only one 300 mg dose taken prior to the 24 hour sampling period, the geometric mean terminal carbovir-TP intracellular half-life at steady-state was 20.6 hours, compared to the geometric mean abacavir plasma half-life in this study of 2.6 hours.
Danish: I et studie af 20 hiv-inficerede patienter, der fik abacavir 300 mg 2 gange daglig, med kun én 300 mg dosis indtaget før prøveudtagning efter 24 timer, var den geometriske gennemsnitlige carbovir-TP intracellulære halveringstid 20,6 timer sammenlignet med den geometriske gennemsnitlige abacavir plasmahalveringstid i dette studie på 2,6 timer.
English: Patients with pre-existing liver dysfunction, including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy, and should be monitored according to standard practice.
Danish: Hos patienter med leverinsufficiens, herunder kronisk aktiv hepatitis, ses oftere abnorm leverfunktion i forbindelse med den antiretrovirale behandling, og disse patienter skal kontrolleres i henhold til standardpraksis.
English: The EU SPC provides detailed information and advice relating to ABC HSR
Danish: EU-produktresuméet indeholder detaljerede oplysninger og rådgivning angående ABC-overfølsomhedsreaktion.
English: LIST OF EXCIPIENTS Contains sunset yellow (E110), see leaflet for further information
Danish: LISTE OVER HJÆLPESTOFFER Indeholder sunset yellow (E110), se indlægssedlen for yderligere oplysninger
English: However, some patients with a suspected ABC hypersensitivity reaction may not have the HLA-B*5701 allele.
Danish: Nogle patienter med en mistænkt overfølsomhedsreaktion over for ABC har dog muligvis ikke HLA-B*5701-allellen.
English: Within this population, 104 patients, weighing at least 25 kg, received 600 mg abacavir and 300 mg lamivudine as Kivexa once daily, with a median duration of exposure of 596 days.
Danish: Indenfor denne population var der 104 patienter, der vejede mindst 25 kg, som fik 600 mg abacavir og 300 mg lamivudin givet 1 gang daglig som Kivexa med en median behandlingsvarighed på 596 dage.
English: HLA-B*5701 screening for risk of ABC hypersensitivity should never be substituted for appropriate clinical vigilance and patient management in individuals receiving ABC.
Danish: HLAB*5701-screening for risiko for overfølsomhed over for ABC må aldrig erstatte relevant klinisk overvågning og behandling af patienter, som får ABC.
English: The tablet coating contains Opadry Orange YS-1-13065-A containing hypromellose, titanium dioxide, macrogol 400, polysorbate 80 and sunset yellow FCF (E110).
Danish: Filmovertræk: Opadry Orange YS-1-13065-A indeholdende hypromellose, titandioxid, macrogol 400, polysorbat 80 og sunset yellow FCF (E110).
English: Following multiple-dose oral administration of lamivudine 300 mg once daily for seven days, the mean (CV) steady-state Cmax is 2.04 µg/ml (26%) and the mean (CV) AUC24 is 8.87 µg.h/ml (21%).
Danish: Efterfølgende flerdosis oral administration af lamivudin 300 mg én gang daglig i syv dage er (CV) steady state Cmax 2,04 µg/ml (26 %) og (CV) AUC24 er 8,87 µg · t/ml (21 %).
English: In pregnant women treated with abacavir, more than 800 outcomes after first trimester exposure and more than 1000 outcomes after second and third trimester exposure indicate no malformative and foetal/neonatal effect.
Danish: Hos gravide kvinder behandlet med abacavir har flere end 800 eksponeringer i første trimester og flere end 1.000 eksponeringer i andet og tredje trimester ikke indikeret misdannende eller føtale/neonatale effekter.
English: Baseline CD4 category 50-100 21/40 (53%)
Danish: Baseline-CD4-kategori 50-100 21/40 (53 %)
English: However, abacavir HSRs have been reported at a lower frequency in patients who do not carry this allele.
Danish: Derimod er frekvensen af en overfølsomhedsreaktion over for abacavir rapporteret med lavere frekvens hos patienter, der ikke er bærer af dette allel.
English: Even patients who don't have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction), described in this leaflet in the panel headed ‘Hypersensitivity reactions'.
Danish: Selv patienter, som ikke har genet HLA-B*5701, kan udvikle en overfølsomhedsreaktion (en alvorlig allergisk reaktion) beskrevet i denne indlægsseddel under overskriften ”Overfølsomhedsreaktioner”.
English: The pharmacokinetic properties of lamivudine and abacavir are described below.
Danish: De farmakokinetiske egenskaber for lamivudin og abacavir er beskrevet nedenfor.
English: HSRs have been observed with abacavir, some of which have been life-threatening, and in rare cases fatal, when not managed appropriately.
Danish: Der er observeret overfølsomhedsreaktioner ved brug af abacavir, nogle af livstruende karakter og i sjældne tilfælde dødelige hvis der ikke gives hensigtsmæssig behandling.
English: Data obtained in patients with moderate to severe hepatic impairment show that lamivudine pharmacokinetics are not significantly affected by hepatic dysfunction.
Danish: Data indhentet hos patienter med moderat til svær nedsat leverfunktion viser at lamivudins farmakokinetik ikke er signifikant påvirket af nedsat leverfunktion.
English: Therefore, patients with any of these symptoms should be carefully evaluated for the presence of this hypersensitivity (see section 4.4).
Danish: Derfor skal patienter, der har et eller flere af disse symptomer, nøje vurderes for at klarlægge, om der er tale om en overfølsomhedsreaktion (se pkt.
English: HIV-1 isolates (CRF01_AE, n=12; CRF02_AG, n=12; and Subtype C or CRF_AC, n=13) from 37 untreated patients in Africa and Asia were susceptible to abacavir (IC50 fold changes <2.5), and lamivudine (IC50 fold changes<3.0), except for two CRF02_AG isolates with fold-changes of 2.9 and 3.4 for abacavir.
Danish: Hiv-1-isolater (CRF01_AE, n=12; CRF02_AG, n=12; og subtype C eller CRF_AC, n=13) fra 37 ubehandlede patienter i Afrika og Asien var følsomme over for abacavir (IC50 < 2,5-gange ændring), og lamivudin (IC50 < 3,0-gange ændring), med undtagelse af to CRF02_AG-isolater med på 2,9- and 3,4gange ændring for abacavir.
English: For patients co-infected with hepatitis who are being treated with a lamivudine containing medicinal product such as Kivexa and subsequently become pregnant, consideration should be given to the possibility of a recurrence of hepatitis on discontinuation of lamivudine.
Danish: Hos patienter, som også er smittet med hepatitis, og som bliver gravide under behandling med et lægemiddel, der indeholder lamivudin, såsom Kivexa, bør det vurderes, om der er en risiko for recidiv af hepatitis ved seponering af lamivudin.
English: Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction (serious allergic reaction) which can be life-threatening if treatment with Kivexa is continued.
Danish: Da Kivexa indeholder abacavir, kan nogle patienter, som tager Kivexa, få en overfølsomhedsreaktion (alvorlig allergisk reaktion), som kan være livstruende, hvis behandling med Kivexa fortsættes.
English: The likelihood of metabolic drug interactions with lamivudine is low due to the small extent of hepatic metabolism (5-10%).
Danish: Sandsynligheden for metaboliske interaktioner mellem lamivudin og andre lægemidler er lav på grund af begrænset levermetabolisme (5-10 %) og lav plasmaproteinbinding.
English: Clinical experience with the combination of abacavir and lamivudine as a once daily regimen is mainly based on four studies in treatment-naïve subjects, CNA30021, EPZ104057 (HEAT study), ACTG5202, and CNA109586 (ASSERT study) and two studies in treatment-experienced subjects, CAL30001 and ESS30008.
Danish: Klinisk erfaring med kombination af abacavir og lamivudin som et én gang daglig regime er primært baseret på fire studier med behandlingsnaive forsøgspersoner, CNA30021, EPZ104057 (HEAT-studiet), ACTG5202 og CNA109586 (ASSERT-studiet) samt to studier med behandlingserfarne forsøgspersoner, CAL30001 og ESS30008.
English: Possible interaction given common pathway of elimination via alcohol dehydrogenase.
Danish: Interaktion ikke undersøgt, men er mulig på grund af fælles eliminationsvej via alkoholdehydrogenase.
English: Almost all patients developing hypersensitivity reactions will have fever and/or rash (usually maculopapular or urticarial) as part of the syndrome, however reactions have occurred without rash or fever.
Danish: Næsten alle patienter, som får overfølsomhedsreaktioner, vil få feber og/eller udslæt (sædvanligvis makulopapuløst eller urtikarielt) som del af syndromet.
English: Kivexa should not be taken with any other medicinal products containing lamivudine (see section 4.4).
Danish: Kivexa bør ikke tages med andre lægemidler, der indeholder lamivudin (se pkt.
English: Cmax ↓ 28%; 52%, 55%.
Danish: AUC  14 %; 32 %; 36 % Cmax  28 %; 52 %; 55 %.
English: This was demonstrated in a single dose, 3-way crossover bioequivalence study of FDC (fasted) versus 2 x 300 mg abacavir tablets plus 2 x 150 mg lamivudine tablets (fasted) versus FDC administered with a high fat meal, in healthy volunteers (n = 30).
Danish: Dette blev demonstreret i en enkeltdosis, 3-vejs overkrydsningsbioækvivalensstudie med FDC (fastende) versus 2 x 300 mg abacavir-tabletter plus 2 x 150 mg lamivudin-tabletter (fastende) mod FDC givet med et måltid med højt fedtindhold til raske frivillige (n=30).
English: Baseline CD4 category 101-200 57/ 85 (67%)
Danish: Baseline-CD4-kategori 101-200 57/ 85 (67 %)
English: Carcinogenicity studies with orally administered abacavir in mice and rats showed an increase in the incidence of malignant and non-malignant tumours.
Danish: Karcinogenicitetsundersøgelser hos mus og rotter af oralt administreret abacavir viste en stigning i forekomsten af ond- og godartede tumorer.
English: Isolates from most patients experiencing virological failure with a regimen containing abacavir in pivotal clinical trials showed either no NRTI-related changes from baseline (45%) or only M184V or M184I selection (45%).
Danish: Isolater fra patienter, som har haft virologisk svigt under en behandling med abacavir i pivotale kliniske studier, viste i de fleste tilfælde enten ingen NRTI-relaterede ændringer i forhold til baseline (45 %) eller kun M184V- eller M1841-mutationer (45 %).
English: Even patients who don't have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction)
Danish: Selv patienter, som ikke har genet HLA-B*5701, kan udvikle en overfølsomhedsreaktion (en alvorlig allergisk reaktion).
English: The antiviral activity of abacavir in cell culture was not antagonized when combined with the nucleoside reverse transcriptase inhibitors (NRTIs) didanosine, emtricitabine, stavudine, tenofovir or zidovudine, the non-nucleoside reverse transcriptase inhibitor (NNRTI) nevirapine, or the protease inhibitor (PI) amprenavir.
Danish: I cellekulturer blev abacavirs antivirale aktivitet ikke antagoniseret ved kombination med nukleosid revers transkriptasehæmmerne (NRTI'er) didanosin, emtricitabin, stavudin, tenofovir eller zidovudin, non-nukleosid revers transkriptasehæmmeren (NNRTI) nevirapin eller proteasehæmmeren (PI) amprenavir.
English: Phenotypic resistance to abacavir requires M184V with at least one other abacavir-selected mutation, or M184V with multiple TAMs.
Danish: Fænotyperesistens over for abacavir kræver M184V med mindst en anden abacavir-mutation eller M184V med flere TAM'er.
English: Phenotypic susceptibility analyses of clinical isolates from antiretroviral-naïve patients with HIV-1 Group M non-B subtypes in three studies have each reported that all viruses were fully susceptible to both abacavir and lamivudine; one study of 104 isolates that included subtypes A and A1 (n=26), C (n=1), D (n=66), and the circulating recombinant forms (CRFs) AD (n=9), CD (n=1), and a complex inter-subtype recombinant_cpx (n=1), a second study of 18 isolates including subtype G (n=14) and CRF_AG (n=4) from Nigeria, and a third study of six isolates (n=4 CRF_AG, n=1 A and n=1 undetermined) from Abidjan (Côte d'Ivoire).
Danish: Analyser af fænotypisk følsomhed af kliniske isolater fra antiretroviral-naive patienter med gruppe M hiv1, non-B subtyper i tre studier har for hvert studie vist, at alle vira var fuldt følsomme over for både abacavir og lamivudin: ét studie af 104 isolater, som inkluderede subtype A og A1 (n=26), C (n=1), D (n=66) og de cirkulerende rekombinante former (CRFs) AD (n=9), CD (n=1) og en kompleks intersubtype rekombinant_cpx (n=1), et andet studie af 18 isolater, herunder subtype G (n=14) og CRF_AG (n=4) fra Nigeria samt et tredje studie af seks isolater (n=4 CRF_AG, n=1 A og n=1 ubestemt) fra Abidjan (Côte d'Ivoire).
English: It is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.
Danish: For at undgå overførsel af hiv anbefales det, at hiv-inficerede mødre under ingen omstændigheder ammer deres børn.
English: IMPORTANT - Hypersensitivity reactions
Danish: VIGTIGT - Overfølsomhedsreaktioner
English: It is important to take Kivexa regularly, because if you take it at irregular intervals, you may be more likely to have a hypersensitivity reaction.
Danish: Det er vigtigt, at du tager Kivexa regelmæssigt, da der er større risiko for at få en overfølsomhedsreaktion, hvis du tager medicinen uregelmæssigt.
English: Four or more NRTIassociated mutations 28
Danish: Fire eller flere NRTIforbundne mutationer
English: ACTG 5202 study was a, multi-centre, comparative, randomised study of double-blind abacavir/lamivudine or emtricitabine/tenofovir in combination with open-label efavirenz or atazanavir/ritonavir in treatment-naïve HIV-1 infected patients.
Danish: Studiet ACTG5202 var et multicenter, randomiseret, sammenlignende studie af dobbeltblindet abacavir/lamivudin eller emtricitabin/tenofovir i kombination med open-label efavirenz eller atazanavir/ritonavir hos behandlingsnaive patienter inficerede med hiv-1.
English: In reproductive toxicity studies in animals, lamivudine and abacavir were shown to cross the placenta.
Danish: I reproduktionstoksicitetsundersøgelser i dyr blev det vist at lamivudin og abacavir passerer placenta.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON BLISTER PACK
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON BLISTERPAKNING
English: Lamivudine: AUC ↔ Zidovudine : AUC ↔
Danish: Lamivudin: AUC  Zidovudin: AUC 